questionsmedicales.fr
Phénomènes physiologiques respiratoires et circulatoires
Phénomènes physiogiques du sang
Hémostase
Hémostase : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hémostase : Questions médicales les plus fréquentes",
"headline": "Hémostase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hémostase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hémostase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes physiogiques du sang",
"url": "https://questionsmedicales.fr/mesh/D001790",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes physiogiques du sang",
"code": {
"@type": "MedicalCode",
"code": "D001790",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.188"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Coagulation sanguine",
"alternateName": "Blood Coagulation",
"url": "https://questionsmedicales.fr/mesh/D001777",
"about": {
"@type": "MedicalCondition",
"name": "Coagulation sanguine",
"code": {
"@type": "MedicalCode",
"code": "D001777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.188.390.150"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fibrinolyse",
"alternateName": "Fibrinolysis",
"url": "https://questionsmedicales.fr/mesh/D005342",
"about": {
"@type": "MedicalCondition",
"name": "Fibrinolyse",
"code": {
"@type": "MedicalCode",
"code": "D005342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.188.390.150.390"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Activation plaquettaire",
"alternateName": "Platelet Activation",
"url": "https://questionsmedicales.fr/mesh/D015539",
"about": {
"@type": "MedicalCondition",
"name": "Activation plaquettaire",
"code": {
"@type": "MedicalCode",
"code": "D015539",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.188.390.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Rétraction du caillot",
"alternateName": "Clot Retraction",
"url": "https://questionsmedicales.fr/mesh/D003018",
"about": {
"@type": "MedicalCondition",
"name": "Rétraction du caillot",
"code": {
"@type": "MedicalCode",
"code": "D003018",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.188.390.600.180"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agrégation plaquettaire",
"alternateName": "Platelet Aggregation",
"url": "https://questionsmedicales.fr/mesh/D010974",
"about": {
"@type": "MedicalCondition",
"name": "Agrégation plaquettaire",
"code": {
"@type": "MedicalCode",
"code": "D010974",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.188.390.600.640"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hémostase",
"alternateName": "Hemostasis",
"code": {
"@type": "MedicalCode",
"code": "D006487",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dimitra Gialamprinou",
"url": "https://questionsmedicales.fr/author/Dimitra%20Gialamprinou",
"affiliation": {
"@type": "Organization",
"name": "Second Neonatal Department and Neonatal Intensive Care Unit (NICU), \"Papageorgiou\" General Hospital, Medical School, Aristotle University of Thessaloniki, Nea Efkarpia, 56403 Thessaloniki, Greece."
}
},
{
"@type": "Person",
"name": "Georgios Mitsiakos",
"url": "https://questionsmedicales.fr/author/Georgios%20Mitsiakos",
"affiliation": {
"@type": "Organization",
"name": "Second Neonatal Department and Neonatal Intensive Care Unit (NICU), \"Papageorgiou\" General Hospital, Medical School, Aristotle University of Thessaloniki, Nea Efkarpia, 56403 Thessaloniki, Greece."
}
},
{
"@type": "Person",
"name": "Christos-Georgios Kontovazainitis",
"url": "https://questionsmedicales.fr/author/Christos-Georgios%20Kontovazainitis",
"affiliation": {
"@type": "Organization",
"name": "Second Neonatal Department and Neonatal Intensive Care Unit (NICU), \"Papageorgiou\" General Hospital, Medical School, Aristotle University of Thessaloniki, Nea Efkarpia, 56403 Thessaloniki, Greece."
}
},
{
"@type": "Person",
"name": "John W Weisel",
"url": "https://questionsmedicales.fr/author/John%20W%20Weisel",
"affiliation": {
"@type": "Organization",
"name": "University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA."
}
},
{
"@type": "Person",
"name": "Giuseppe Lippi",
"url": "https://questionsmedicales.fr/author/Giuseppe%20Lippi",
"affiliation": {
"@type": "Organization",
"name": "Section of Clinical Biochemistry, University of Verona, P.le LA Scuro 10, Verona 37134, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!",
"datePublished": "2023-06-17",
"url": "https://questionsmedicales.fr/article/37374373",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medicina59061169"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparative analysis on characteristics of two activated partial thromboplastin time reagents.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35853032",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcla.24608"
}
},
{
"@type": "ScholarlyArticle",
"name": "The utility of the dilute prothrombin time in the interpretation of antiphospholipid syndrome testing.",
"datePublished": "2024-05-14",
"url": "https://questionsmedicales.fr/article/38741421",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/ajcp/aqae044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of Electrode Configuration and Morphology in Printed Prothrombin Time Sensors.",
"datePublished": "2023-10-14",
"url": "https://questionsmedicales.fr/article/37953965",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.snb.2023.134785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Falsely prolonged prothrombin time test in a patient with erythrocytosis: a case report.",
"datePublished": "2024-01-26",
"url": "https://questionsmedicales.fr/article/38305118",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MBC.0000000000001276"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques respiratoires et circulatoires",
"item": "https://questionsmedicales.fr/mesh/D002943"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiogiques du sang",
"item": "https://questionsmedicales.fr/mesh/D001790"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hémostase",
"item": "https://questionsmedicales.fr/mesh/D006487"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hémostase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hémostase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hémostase",
"description": "Comment évaluer l'hémostase chez un patient ?\nQuels signes indiquent un trouble de l'hémostase ?\nQuels tests sanguins sont utilisés pour l'hémostase ?\nComment diagnostiquer une thrombose ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006487?mesh_terms=Prothrombin+Time&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hémostase",
"description": "Quels sont les symptômes d'une hémorragie interne ?\nComment reconnaître une thrombose veineuse profonde ?\nQuels symptômes indiquent une coagulation intravasculaire disséminée ?\nQuels signes cliniques sont associés à une carence en vitamine K ?\nQuels symptômes peuvent indiquer un trouble plaquettaire ?",
"url": "https://questionsmedicales.fr/mesh/D006487?mesh_terms=Prothrombin+Time&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hémostase",
"description": "Comment prévenir les thromboses chez les patients à risque ?\nQuelles mesures préventives pour les troubles de la coagulation ?\nComment réduire le risque d'hémorragie pendant une chirurgie ?\nQuels conseils pour les patients sous anticoagulants ?\nComment la nutrition influence-t-elle l'hémostase ?",
"url": "https://questionsmedicales.fr/mesh/D006487?mesh_terms=Prothrombin+Time&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hémostase",
"description": "Quels traitements sont disponibles pour les troubles de l'hémostase ?\nComment traiter une thrombose ?\nQuel est le rôle de la vitamine K dans le traitement ?\nComment gérer une hémorragie sévère ?\nQuels médicaments sont utilisés pour traiter les troubles plaquettaires ?",
"url": "https://questionsmedicales.fr/mesh/D006487?mesh_terms=Prothrombin+Time&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hémostase",
"description": "Quelles complications peuvent survenir avec une hémorragie ?\nQuels risques sont associés à une thrombose non traitée ?\nComment une carence en facteur de coagulation affecte-t-elle la santé ?\nQuelles complications peuvent résulter d'un traitement anticoagulant ?\nQuels effets secondaires des médicaments hémostatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006487?mesh_terms=Prothrombin+Time&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hémostase",
"description": "Quels sont les facteurs de risque de thrombose ?\nComment l'âge influence-t-il l'hémostase ?\nQuel rôle joue la génétique dans les troubles de l'hémostase ?\nQuels médicaments augmentent le risque de saignement ?\nComment le mode de vie affecte-t-il l'hémostase ?",
"url": "https://questionsmedicales.fr/mesh/D006487?mesh_terms=Prothrombin+Time&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'hémostase chez un patient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme le temps de prothrombine et le temps de saignement sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un trouble de l'hémostase ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements excessifs, des ecchymoses fréquentes ou des saignements spontanés."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés pour l'hémostase ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le temps de prothrombine, le temps de thromboplastine partielle."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer une thrombose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie Doppler et les tests de D-dimères sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il aide à identifier des antécédents de troubles hémorragiques ou thrombotiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une hémorragie interne ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs abdominales, faiblesse, vertiges, et parfois des selles noires."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une thrombose veineuse profonde ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gonflement, douleur et rougeur dans la jambe affectée sont des signes clés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une coagulation intravasculaire disséminée ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Saignements, ecchymoses, et défaillance d'organes peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une carence en vitamine K ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Saignements des gencives, hématomes et saignements prolongés après une coupure."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un trouble plaquettaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Saignements de nez fréquents, ecchymoses et saignements menstruels abondants."
}
},
{
"@type": "Question",
"name": "Comment prévenir les thromboses chez les patients à risque ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation d'anticoagulants, l'exercice régulier et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives pour les troubles de la coagulation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les médicaments qui augmentent le risque de saignement et surveiller les niveaux de coagulation."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque d'hémorragie pendant une chirurgie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation préopératoire complète et l'utilisation de médicaments hémostatiques sont essentielles."
}
},
{
"@type": "Question",
"name": "Quels conseils pour les patients sous anticoagulants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les activités à risque, surveiller les signes de saignement et suivre les rendez-vous médicaux."
}
},
{
"@type": "Question",
"name": "Comment la nutrition influence-t-elle l'hémostase ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, riche en vitamine K et en acides gras oméga-3, favorise une bonne hémostase."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles de l'hémostase ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des anticoagulants, des transfusions de plaquettes et des médicaments spécifiques."
}
},
{
"@type": "Question",
"name": "Comment traiter une thrombose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants comme l'héparine ou la warfarine sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Quel est le rôle de la vitamine K dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est essentielle pour la synthèse des facteurs de coagulation et peut être administrée en cas de carence."
}
},
{
"@type": "Question",
"name": "Comment gérer une hémorragie sévère ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures d'urgence comme la compression, les transfusions et les médicaments hémostatiques sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter les troubles plaquettaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents comme l'acide acétylsalicylique ou des inhibiteurs de la glycoprotéine IIb/IIIa peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une hémorragie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le choc hypovolémique, l'anémie et la défaillance d'organes."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à une thrombose non traitée ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une embolie pulmonaire, des lésions tissulaires et des complications mortelles."
}
},
{
"@type": "Question",
"name": "Comment une carence en facteur de coagulation affecte-t-elle la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des saignements excessifs, augmentant le risque d'hémorragies graves."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'un traitement anticoagulant ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des saignements, des hématomes et des interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des médicaments hémostatiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des réactions allergiques, des troubles gastro-intestinaux et des thromboses."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de thrombose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme, l'immobilisation prolongée et les antécédents familiaux augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il l'hémostase ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le vieillissement peut affecter la fonction plaquettaire et la coagulation, augmentant le risque de troubles."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans les troubles de l'hémostase ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations génétiques peuvent prédisposer à des troubles de la coagulation ou à des saignements."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque de saignement ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants, les anti-inflammatoires non stéroïdiens et certains antibiotiques peuvent augmenter ce risque."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie affecte-t-il l'hémostase ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée, le manque d'exercice et le stress peuvent perturber l'hémostase."
}
}
]
}
]
}
Activated partial thromboplastin time (aPTT) is a fundamental screening test for coagulation disturbances. An increased aPTT ratio is quite common in clinical practice. How the detection of prolonged ...
For the lack of standardized activated partial thromboplastin time (APTT), it has been pointed out that there are differences in values among several reagents. Recently, we have performed a parallel m...
In order to clarify the factors related to ΔAPTT, multiple regression analysis was performed on 8324 samples, using clinical laboratory data of all test items requested simultaneously with APTT. To co...
Multiple regression analysis detected albumin-globulin ratio (AGR), C-reactive protein (CRP), hematocrit, and prothrombin time as factors related to ΔAPTT (p < 0.001). Results revealed no significant ...
It is considered that the pseudo-prolongation of APTT is triggered by the interaction of CRP on the phospholipid in Coagpia APTT-n, which contributed to the APTT dissociation....
To evaluate the utility of the dilute prothrombin time (DPT) in diagnosing antiphospholipid syndrome (APS), alone and when paired with the dilute Russell viper venom time (DRVVT)....
Dilute prothrombin time and DRVVT testing was performed on plasma samples spiked with apixaban or rivaroxaban, or depleted of vitamin K-dependent clotting factors. A retrospective analysis of all func...
In spiking studies, the screening clotting time in the DPT (DPTS) is more sensitive to deficiency of vitamin K-dependent factors than is the screening clotting time in the DRVVT (DRVVTS). The converse...
Dilute prothrombin time lupus anticoagulant assay is rarely the sole laboratory functional evidence for APS, but when combined with the DRVVT, the DPT can serve as an effective screen for common antic...
Patients on long-term anticoagulation therapy require frequent testing of prothrombin time/international normalized ratio (PT/INR) to ensure therapeutic efficacy. Point-of-care (POC) PT tests for at-h...
The prothrombin time (PT) test is commonly used to monitor deficiencies in coagulation factors. A prolonged PT may indicate a deficiency of factors II, V, VII, X, and fibrinogen, or the presence of an...
Guidelines recommend "rapid" and "urgent" reversal of anticoagulation for warfarin-associated intracranial hemorrhage (ICH) treatment; however, they do not specify goals for time-to-administration. Th...
This was a retrospective, observational, single center study performed at a large community teaching hospital. Patients were stratified into three groups based on time of CT diagnosis of ICH to admini...
A total of 227 patients were screened for inclusion with ultimately 39 being included. Baseline characteristics were similar between groups. The primary outcome was not significantly different among g...
There was no association with time-to-administration of 4F-PCC on rates of hemostasis achievement, defined as hematoma expansion of ≤20%, identified in this study....
Alcohol-related hepatitis (AH) is the most severe form of acute alcohol-related liver disease. Maddrey's discriminant function ≥32 defines the severe form of AH, which is associated with a high mortal...
Patients consecutively admitted in two Italian Liver Units, from 2017 to 2022, suffering from sAH were included. Data were collected prospectively. In order to evaluate if BPT could predict steroid re...
A total of 52 patients received steroid treatment were enrolled in the study. The response to therapy was assessed by Lille score at day 7. Responders were 34 patients (65%), non-responders 18 patient...
BPT value predicted steroid response in patients with sAH. BPT could quickly identify non-responder patients to steroid therapy, reducing the risk of infections and it could allow the early evaluation...
Patients with adenomyosis are hypercoagulable and often accompanied by anemia, but the specific changes in anemia-related coagulation parameters are still unclear. This study investigated the changes ...
The ordering of clinical haemostasis tests is increasing in Burkina Faso due to the newly emergence of cardiovascular and metabolic diseases. However, appropriate local reference values (RV) are lacki...
Genotype-guided dosing algorithms can explain about half of the interindividual variability in prothrombin time-international normalized ratio (PT-INR) under warfarin treatment. This study aimed to re...
Using a retrospective cohort of adult patients (>20 years) who were administered warfarin and underwent PT-INR measurements, we refined the kinetic-pharmacodynamic model with age and the genotypes of ...
A total of 350 patients with 2762 PT-INR measurements were enrolled (estimated glomerular filtration rate [eGFR]: 47.5 [range: 2.6-199.0] mL/min/1.73 m...
Model-informed precision dosing of warfarin is a valuable approach for estimating its dosage in patients with renal impairment....